Human IRAK-2
US6653452B2 · kind B2 · utility
0Cited by
3References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 2, 2001 |
| Grant date | Nov 25, 2003 |
| Priority date | — |
| Expiry date | Apr 20, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel IRAK-2 protein which is a member of the IL-1 signaling pathway. In particular, isolated nucleic acid molecules are provided encoding the human IRAK-2 protein. IRAK-2 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic methods for detecting IRAK-2 related disorders and therapeutic methods for treating IRAK-2 related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.